Executive Committee: Kymera Therapeutics, Inc.

Manager
Positions heldSince
Nello Mainolfi

Nello Mainolfi

47 year

Chief Executive Officer 31/10/2019
Founder 28/09/2015
President 31/05/2019
Vijay Sabesan

Vijay Sabesan

53 year

Chief Tech/Sci/R&D Officer 05/12/2021
Justine E. Koenigsberg

Justine E. Koenigsberg

Investor Relations Contact 30/06/2023
Public Communications Contact 30/06/2023
Jeremy Chadwick

Jeremy Chadwick

63 year

Chief Operating Officer 21/05/2023
Aimee Mishkin

Aimee Mishkin

General Counsel 31/03/2022
Karen Weisbach

Karen Weisbach

Human Resources Officer 28/07/2021
Jared Gollob

Jared Gollob

62 year

Chief Tech/Sci/R&D Officer 31/08/2018
Bruce Jacobs

Bruce Jacobs

56 year

Director of Finance/CFO 14/07/2019
Brian Adams

Brian Adams

52 year

General Counsel 02/09/2025
Corporate Secretary 02/09/2025

Composition of the Board of Directors: Kymera Therapeutics, Inc.

Director
CommitteesSince
Bruce Booth

Bruce Booth

51 year

Compensation Committee
John Maraganore

John Maraganore

62 year

Governance Committee Chair
Nominating Committee Chair
Compensation Committee 29/02/2024
Audit Committee 29/02/2024
Felix Baker

Felix Baker

57 year

Governance Committee
Nominating Committee 31/08/2018
Compensation Committee Chair 31/08/2018
Compensation Committee 27/03/2024
Gorjan Hrustanovic

Gorjan Hrustanovic

37 year

Governance Committee 29/02/2020
Nominating Committee 29/02/2020
Compensation Committee 30/06/2018
Jeffrey Albers

Jeffrey Albers

54 year

Audit Committee
Compensation Committee Chair
Compensation Committee
Pamela Esposito

Pamela Esposito

52 year

Audit Committee
Governance Committee Chair
Nominating Committee Chair
Victor Sandor

Victor Sandor

59 year

Compensation Committee 26/04/2020
Governance Committee 30/04/2020
Nominating Committee 30/04/2020
Elena Ridloff

Elena Ridloff

46 year

Audit Committee Chair 11/03/2021
Nello Mainolfi

Nello Mainolfi

47 year

Director/Board Member 31/10/2019

Former Officers and Directors: Kymera Therapeutics, Inc.

Insider
Positions held
SinceUntil
Melissa Brody
Melissa Brody
Corporate Officer/Principal 01/11/2021 31/10/2025
Ellen Chiniara
Ellen Chiniara
General Counsel 03/01/2023 02/09/2025
Corporate Secretary 03/01/2023 02/09/2025
Leigh Morgan
Leigh Morgan
Director/Board Member 07/07/2022 24/06/2025
Independent Dir/Board Member 07/07/2022 24/06/2025
Kevin Dushney
Kevin Dushney
Chief Tech/Sci/R&D Officer 30/06/2022 01/06/2025
Ashwin Gollerkeri
Ashwin Gollerkeri
Corporate Officer/Principal 02/02/2021 30/11/2024
Joanna Horobin
Joanna Horobin
Director/Board Member 30/04/2018 17/06/2024
Independent Dir/Board Member 30/04/2018 17/06/2024
Michael J. Todisco
Michael J. Todisco
Comptroller/Controller/Auditor - 31/08/2023
Jeff Davis
Jeff Davis
Chief Tech/Sci/R&D Officer - 30/06/2023
Elaine Caughey
Elaine Caughey
Corporate Officer/Principal 20/06/2021 09/04/2023
Donald Nicholson
Donald Nicholson
Director/Board Member 31/10/2017 02/11/2022
Independent Dir/Board Member 31/10/2017 02/11/2022
Tyler Gagnon
Tyler Gagnon
Public Communications Contact 31/08/2021 30/09/2022
Karen Martin
Karen Martin
General Counsel 02/02/2021 30/09/2022
Corporate Officer/Principal 31/03/2020 02/02/2021
Steve Hall
Steve Hall
Director/Board Member 31/07/2017 14/06/2022
Independent Dir/Board Member 31/07/2017 14/06/2022
Richard Chesworth
Richard Chesworth
Chief Tech/Sci/R&D Officer 26/08/2020 21/10/2021
Paige Cochran
Paige Cochran
Human Resources Officer 31/07/2018 31/07/2021
Andrew Hedin
Andrew Hedin
Director/Board Member 12/11/2018 15/06/2021
Independent Dir/Board Member 12/11/2018 15/06/2021
Wei Li
Wei Li
Director/Board Member 12/11/2018 30/08/2020
Sharon Townson
Sharon Townson
Director/Board Member 31/03/2019 31/05/2020
Corporate Officer/Principal 31/03/2019 31/05/2020
Laurent Audoly
Laurent Audoly
Director/Board Member - 31/05/2019
Chief Executive Officer - 31/05/2019
President - 31/05/2019
Christopher O’Donnell
Christopher O’Donnell
Director/Board Member 30/04/2019 -
Elaine Jones
Elaine Jones
Director/Board Member 12/11/2018 -
Stuart Chaffee
Stuart Chaffee
Corporate Officer/Principal 31/05/2016 31/10/2017
Greg Hunt
Greg Hunt
Director/Board Member - -
Steven Robinette
Steven Robinette
Private Equity Investor - -
Duncan Walker
Duncan Walker
Corporate Officer/Principal - -
Christopher F. Brinzey
Christopher F. Brinzey
Public Communications Contact - -
Paul Cox
Paul Cox
Investor Relations Contact - -
Public Communications Contact - -

Age distribution of managers

Parity Men Women

Male16
Female4

Of which Executive Committee

Male6
Female3

Of which Directors

Male8
Female1

Revisions

Recommandations analystes
-
Évolution recommandations analystes 1 an
-
Évolution recommandations analystes 4 mois
-
Objectif analystes
-
Évolution objectif analystes 1 an
-
Évolution objectif analystes 4 mois
-
ESG MSCI

ESG MSCI

Environnement
Social
Gouvernance
Polémique
Controverses Ethiques
No
Controverses sur les droits de l'Homme
No
Controverses Subventions fiscales
No
Conforme à la finance Islamique
-
Logo Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. The Company's targeted protein degradation (TPD) platform, which it refers to as Pegasus, allows it to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. It utilized its Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and it continues to apply its platform’s capabilities to additional therapeutic areas. Its clinical stage programs are IRAK4, STAT3, and MDM2, which each address high impact targets within biologically proven pathways, providing the opportunity to treat a range of immuno-inflammatory diseases, hematologic malignancies, and/or solid tumors.
Employees
238

Departures of Key Persons

Laurent Audoly
-
Laurent Audoly

Chief Executive Officer

- 31/05/2019